Mirtazapine Tablet, Film Coated
Product Images NDC 55154-5355

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 55154-5355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5d79b23a C888 4c99 A70c 8ecfb0376be2 00

Label for Mirtazapine tablets, USP 15 mg, film-coated tablets. The label states the package contains 10 tablets. It includes product details such as dosage form and appearance, storage instructions, and warnings. Manufactured by Mylan Pharmaceuticals Inc., made in Australia, and distributed by Cardinal Health, Dublin, OH. The label also shows the NDC 55154-5355-0 and notes RX only and institutional use.*

FDA Label Image

Image 04

Chemical structure of mirtazapine, illustrating the molecular arrangement of rings and nitrogen atoms characteristic of this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.